Single-institution experience of venetoclax combined with azacitidine in newly diagnosed acute myeloid leukemia patients.
Yu H, Wang C, Lei Y, Li L, Wang H, Wang G, Xing L, Guan J, Song J, Wu Y, Liu H, Qu W, Wang X, Shao Z, Fu R.
Yu H, et al. Among authors: shao z.
Int Immunopharmacol. 2024 Jan 25;127:111232. doi: 10.1016/j.intimp.2023.111232. Epub 2023 Dec 13.
Int Immunopharmacol. 2024.
PMID: 38091830
Free article.